Cargando…

BAP31, a promising target for the immunotherapy of malignant melanomas

PURPOSE: Malignant melanoma’s (MM) incidence is rising faster than that of any other cancer in the US and the overall survival at 5 years is less than 10%. B cell associated protein 31 (BAP31) is overexpressed in most MMs and might be a promising target for immunotherapy of this disease. EXPERIMENTA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shaojuan, Wang, Fuli, Fan, Li, Wei, Yuying, Li, Haitao, Sun, Yuanjie, Yang, Angang, Jin, Boquan, Song, Chaojun, Yang, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405826/ https://www.ncbi.nlm.nih.gov/pubmed/25903101 http://dx.doi.org/10.1186/s13046-015-0153-6

Ejemplares similares

BAP31, a newly defined cancer/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression
por: Dang, Erle, et al.
Publicado: (2018)

BAP31 Promotes Tumor Cell Proliferation by Stabilizing SERPINE2 in Hepatocellular Carcinoma
por: Zhang, Xiyang, et al.
Publicado: (2020)

MiR‐362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway
por: Yang, Shuya, et al.
Publicado: (2020)

Structural and Biophysical Characterization of the Cytoplasmic Domains of Human BAP29 and BAP31
por: Quistgaard, Esben M., et al.
Publicado: (2013)

BAP31 regulates IRAK1-dependent neuroinflammation in microglia
por: Liu, Xia, et al.
Publicado: (2019)

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012)

Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients
por: Xu, Zhuwei, et al.
Publicado: (2009)

BAP31 is involved in T cell activation through TCR signal pathways
por: Niu, Kunwei, et al.
Publicado: (2017)

Export of Cellubrevin from the Endoplasmic Reticulum Is Controlled by BAP31
por: Annaert, Wim G., et al.
Publicado: (1997)

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
por: Figueiredo, Carlos R, et al.
Publicado: (2020)

BAP31 Regulates Wnt Signaling to Modulate Cell Migration in Lung Cancer
por: Li, Tianye, et al.
Publicado: (2022)

Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin
por: Liu, Jingjing, et al.
Publicado: (2023)

Induction of Liver Steatosis in BAP31-Deficient Mice Burdened with Tunicamycin-Induced Endoplasmic Reticulum Stress
por: Wu, Zhenhua, et al.
Publicado: (2018)

Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
por: Stålhammar, Gustav, et al.
Publicado: (2021)

Germline BAP1 mutations predispose to malignant mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2011)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

The promise of immunotherapy in genitourinary malignancies
por: Zhang, Tian, et al.
Publicado: (2018)

BAP1 suppresses lung cancer progression and is inhibited by miR-31
por: Yu, Mengchao, et al.
Publicado: (2016)

BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma
por: Murrone, Albero, et al.
Publicado: (2021)

Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma
por: Liu-Smith, Feng, et al.
Publicado: (2020)

BAP1 PLAYS A SURVIVAL ROLE IN CUTANEOUS MELANOMA
por: Kumar, Raj, et al.
Publicado: (2014)

An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome
por: Young, Kelly Z., et al.
Publicado: (2020)

Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma
por: Djulbegovic, Mak B., et al.
Publicado: (2022)

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
por: Pulford, Emily, et al.
Publicado: (2017)

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
por: Ladanyi, Marc, et al.
Publicado: (2019)

MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer
por: Xu, Ke, et al.
Publicado: (2019)

Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma
por: Masoomian, Babak, et al.
Publicado: (2018)

Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma
por: Yen, Matthew, et al.
Publicado: (2018)

A population-based analysis of germline BAP1 mutations in melanoma
por: O’Shea, Sally J., et al.
Publicado: (2017)

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Bakhoum, Mathieu F., et al.
Publicado: (2021)

Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
por: Song, Hao, et al.
Publicado: (2017)

RhierBAPS: An R implementation of the population clustering algorithm hierBAPS
por: Tonkin-Hill, Gerry, et al.
Publicado: (2018)

Progress of immunotherapy in the treatment of malignant melanoma.
por: Ariyan, S.
Publicado: (1975)

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
por: Matatall, Katie A, et al.
Publicado: (2013)

Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Can BAP1 expression loss in mesothelial cells be an indicator of malignancy?
por: Ozdemir, Hanife Gulnihal, et al.
Publicado: (2020)

Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families
por: Njauw, Ching-Ni Jenny, et al.
Publicado: (2012)

Clinical outcome of 31 patients with primary malignant melanoma of the vagina
por: Huang, Qidan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nn709b5s4g61ee2oj0f2e6ubai